[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 1972

Half-Life of Methotrexate: New Evidence-Reply

Arch Dermatol. 1972;105(5):762. doi:10.1001/archderm.1972.01620080084031

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor.—  Doctors Huffman et al are quite correct that the fluorometric assay method is relatively insensitive, that is, its lower limit of sensitivity is 0.1μg/ml. As a matter of fact, on all of the graphs in the article referred to, the ordinate which shows the serum methotrexate concentration uses 0.1μg/ml as its lower limit instead of (0), since the test did not provide sensitivity below this level.Doctors Huffman et al do not say whether they gave the methotrexate intravenously, intramuscularly, or orally. By the "distribution" phase, I presume they mean the time it takes for the drug not only to distribute within the bloodstream, but also to disseminate out to the tissues and to equilibrate in the extracellular and, perhaps, intracellular space. This kind of measurement cannot be made if the drug is given intramuscularly or orally, since absorption is going on at the same time as

First Page Preview View Large
First page PDF preview
First page PDF preview